INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

Go back to INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
(NASDAQ: INMB) Delayed: 2.33 +0.15 (6.88%)
Previous Close $2.18    52 Week High
Open $2.22    52 Week Low
Day High $2.40    P/E N/A 
Day Low $2.21    EPS
Volume 677,642       

(NASDAQ: INMB) Delayed: 2.33 +0.15 (6.88%)
Previous Close $2.18    52 Week High
Open $2.22    52 Week Low
Day High $2.40    P/E N/A 
Day Low $2.21    EPS
Volume 677,642